AbbVie

+$0.73 (+0.68%) As of 1:39 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.

CEO

Richard A. Gonzalez

Employees

47,000

Headquarters

North Chicago, Illinois

Founded

2011

ABBV Key Statistics

Market Cap

Price-Earnings Ratio

29.20

Dividend Yield

4.69

Average Volume

5.51M

High Today

$109.14

Low Today

$108.22

Open Price

$108.39

Volume

399.46K

52 Week High

$121.53

52 Week Low

$79.11

ABBV News

Benzinga24h

Price Over Earnings Overview: AbbVie

In the current market session, AbbVie Inc. (NYSE:ABBV) is trading at $109.16, after a 0.30% decrease. However, over the past month, the stock increased by 0.29%

Simply Wall StOct 25

Investors in AbbVie have made a strong return of 138% over the past five years

The main point of investing for the long term is to make money. But more than that, you probably want to see it rise more than the market average. Unfortunately

Analyst Ratings

71%

of 21 ratings

Buy

71.4%

Hold

28.6%

Sell

ABBV Earnings

$0.00

$1.08

$2.15

$3.23

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

$3.23 per share

Actual

Available Oct 29, Pre-Market

Preview Earnings Call